Skip to main content
. 2014 May 12;9(5):e97531. doi: 10.1371/journal.pone.0097531

Table 1. Baseline characteristics of all patients, and patients with and without recurrent ischemic stroke in the territory of the qualifying artery.

Characteristics a Overall (N = 32) Recurrent ischemic stroke in the territory P values b
Yes (n = 6) No (n = 26)
Baseline characteristics
Age, y 65 (57–72) 65 (54–70) 65 (58–74) 0.612
Male 19 (59.4) 3 (50.0) 16 (61.5) 0.666
Current smoker 15 (46.9) 3 (50.0) 12 (46.2) 1.000
History of dyslipidemia 27 (84.4) 6 (100) 21 (80.8) 0.555
History of hypertension 24 (75.0) 5 (83.3) 19 (73.1) 1.000
History of diabetes mellitus 13 (40.6) 4 (66.7) 9 (34.6) 0.194
History of ischemic stroke / TIA 5 (15.6) 1 (16.7) 4 (15.4) 1.000
Laboratory tests
Fasting blood glucose, mmol/L 6.8±2.4 7.6 (5.3–12.9) 5.7 (5.2–7.1) 0.109
Glycosylated hemoglobin, % 6.6±1.6 7.8 (6.1–10.9) 6.1 (5.6–6.5) 0.030
Triglycerides, mmol/L 1.6±0.8 1.5 (1.1–3.1) 1.3 (1.2–1.7) 0.546
High-density lipoprotein, mmol/L 1.2±0.4 0.9 (0.8–1.4) 1.1 (1.0–1.4) 0.190
Low-density lipoprotein, mmol/L 3.4±1.3 3.5 (1.4–4.9) 3.4 (2.6–4.0) 0.981
Characteristics of ICAS
Percentage of luminal stenosis by DSA, % 76 (70–87) 80 (71–87) 76 (70–84) 0.697
Percentage of cross-sectional stenosis by DSA, % 94 (91–98) 95 (91–98) 94 (91–97) 0.697
Hemodynamic characteristics on CFD models
Pressure ratio 0.40 (−2.46–0.79) −0.80 (−46.48–0.78) 0.47 (−2.28–0.80) 0.412
SSR ratio 4.5 (2.2–20.6) 22.6 (8.4–87.9) 3.5 (1.9–9.1) 0.038
Velocity ratio 7.4 (5.2–12.5) 12.1 (9.1–77.1) 6.5 (4.7–12.0) 0.038

TIA, transient ischemic attack; ICAS, intracranial atherosclerosis; DSA, digital subtraction angiography; CFD, computational fluid dynamics; SSR, shear strain rate.

a

Values are means ± standard deviation, medians (interquartile range) or numbers (%).

b

P values for Wilcoxon rank-sum tests or Fisher's exact tests, respectively for continuous and categorical variables.